Effects of Hypocaloric Low-Fat, Ketogenic, and Ketogenic and Ketone Supplement Diets on Aldosterone and Renin.
adiposity
aldosterone
ketogenic diet
ketones
renin
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
16 Jun 2023
16 Jun 2023
Historique:
received:
11
08
2022
pmc-release:
11
01
2024
medline:
19
6
2023
pubmed:
12
1
2023
entrez:
11
1
2023
Statut:
ppublish
Résumé
Ketogenic diets (KDs) and low-fat diets (LFD) result in similar weight loss, but have differential cardiometabolic effects on lipids and insulin. Generally, weight loss decreases renin-angiotensin-aldosterone system (RAAS) activity. Investigate the effects of KDs with varying sodium content vs LFD on RAAS in overweight and obese adults. Twenty-eight participants were randomized 1:1 to a KD + ketone salt supplement (KD + KS) or a KD + placebo (KD + PL) arm with prepared hypocaloric meals. Twelve participants were enrolled in a post hoc LFD arm. Serum renin, aldosterone, and anthropometric and metabolic biomarkers were assessed at 0, 2, 4, and 6 weeks. Linear mixed models with random intercepts were used to compare between group differences controlling for sex and body mass index. Participants had a median age of 33 years, 51% female, weighed 91.3 kg, with body mass index 30.6 kg/m2. At 6 weeks, weight decreased by 6, 8, and 7 kg on average in the KD + KS, KD + PL, and LFD groups, respectively (P < .05). Aldosterone increased by 88% and 144% in the KD + PL and KD + KS groups, respectively, but did not change in the LFD after 6 weeks while renin decreased across groups. Systolic and diastolic blood pressure did not change in the KD + PL and KD + KS groups. Log ketones were positively associated with aldosterone (P < .001). Aldosterone was not associated with cardiovascular measures including blood pressure and ejection fraction (P > .05). KD reduced weight and increased aldosterone without worsening cardiometabolic risk factors. Future KD studies are needed to elucidate mechanistic connections between ketones and aldosterone.
Identifiants
pubmed: 36629058
pii: 6983966
doi: 10.1210/clinem/dgad009
pmc: PMC10271230
doi:
Substances chimiques
Ketones
0
Renin
EC 3.4.23.15
Aldosterone
4964P6T9RB
Ketone Bodies
0
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1727-1739Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK117041
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23DK117041
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):110-4
pubmed: 18718746
Obes Res. 2002 Oct;10(10):985-90
pubmed: 12376578
PLoS One. 2014 Nov 21;9(11):e113605
pubmed: 25415333
Curr Opin Investig Drugs. 2008 Sep;9(9):963-9
pubmed: 18729003
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Int J Obes Relat Metab Disord. 2001 Feb;25(2):239-42
pubmed: 11410826
Am J Cardiol. 1986 Mar 1;57(8):613-8
pubmed: 3513521
Int J Sports Med. 2015 May;36(5):414-8
pubmed: 25700097
Eur J Clin Nutr. 2013 Aug;67(8):789-96
pubmed: 23801097
Front Nutr. 2021 Mar 24;8:618520
pubmed: 33869263
Am J Clin Nutr. 1986 Sep;44(3):341-8
pubmed: 3529916
Hypertens Res. 2013 Oct;36(10):895-901
pubmed: 23657296
J Clin Endocrinol Metab. 2008 Jul;93(7):2566-71
pubmed: 18445663
Hypertension. 2012 May;59(5):1069-78
pubmed: 22493070
J Nutr Metab. 2012;2012:472396
pubmed: 22496969
Circulation. 2016 Dec 6;134(23):1866-1880
pubmed: 27803035
J Am Heart Assoc. 2018 Sep 4;7(17):e009890
pubmed: 30371168
J Hypertens Suppl. 1989 Dec;7(6):S206-7
pubmed: 2632719
J Am Coll Nutr. 1985;4(2):225-31
pubmed: 3894477
J Leukoc Biol. 2004 Sep;76(3):676-84
pubmed: 15240753
Nat Rev Nephrol. 2013 Aug;9(8):459-69
pubmed: 23774812
J Endocr Soc. 2022 Mar 23;6(6):bvac049
pubmed: 35475027
Hypertension. 2008 Feb;51(2):161-7
pubmed: 18172061
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
Nat Med. 2015 Mar;21(3):263-9
pubmed: 25686106
J Clin Endocrinol Metab. 2023 Jun 16;108(7):1727-1739
pubmed: 36629058
Pharmacol Rep. 2007 Jul-Aug;59(4):437-46
pubmed: 17901573
Steroids. 2014 Dec;91:54-60
pubmed: 25194457
Hypertension. 1982 Sep-Oct;4(5):686-91
pubmed: 7049921
JCI Insight. 2019 Jun 20;4(12):
pubmed: 31217353
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
N Engl J Med. 2004 Jul 1;351(1):33-41
pubmed: 15229305
Nat Commun. 2020 May 1;11(1):2127
pubmed: 32358544
Nat Rev Nephrol. 2010 May;6(5):261-73
pubmed: 20234356
Cardiovasc Res. 2002 Mar;53(4):822-30
pubmed: 11922892
Hypertension. 2005 Mar;45(3):356-62
pubmed: 15630041
Curr Nutr Rep. 2018 Sep;7(3):97-106
pubmed: 30128963
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Tomography. 2019 Dec;5(4):358-366
pubmed: 31893234
Heart Fail Rev. 2005 Jan;10(1):31-7
pubmed: 15947889
N Engl J Med. 1981 Apr 16;304(16):930-3
pubmed: 7010165
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Horm Metab Res. 2007 Sep;39(9):694-9
pubmed: 17846979
Nutrients. 2021 Mar 17;13(3):
pubmed: 33802651
Obes Res. 1999 Jul;7(4):355-62
pubmed: 10440591
Lipids. 2008 Jan;43(1):65-77
pubmed: 18046594